Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Authorized generic Flomax

Executive Summary

Ranbaxy will launch tamsulosin capsules (generic Flomax) in March 2010 under an agreement with Astellas/Boehringer Ingelheim settling patent litigation, the generic firm announces Nov. 8. The settlement allows Ranbaxy to introduce a generic version of the treatment for benign prostatic hyperplasia prior to the expiration of pediatric exclusivity for Flomax, assuming it is granted by FDA. During the period of exclusivity, Ranbaxy will be the only generic firm in the market with the product. The firm's ANDA received tentative approval in June...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS049014

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel